Pharma-Healthcare best performer
India Life Sciences Fund has raised US$250 million for its third growth capital fund for the healthcare and pharmaceutical sector from America and European Investors.
The investors include blue chip fund-of-fund vehicles, pension funds and university endowments as well as family offices, reported The Economic Times.
“The demand for quality medicines and quality healthcare in India is very strong,” The Economic Times quoted Hari Buggana, chairman and managing director of InvAscent Investment Advisors.
“In addition, globally, there is a demand for high quality and low-cost medicines. And Indian firms are very good at addressing this demand,” said Buggana.
Pharmaceuticals and healthcare sector remains the best performer for investment exits with a 213% investment growth between 2015 and 2017 compared to 2009-11 and the median internal rate of return stood at 19%, McKinsey said in November 2018, according to a McKinsey & Company report of November 2018.
The year 2018 also witnessed record fund raising activity by India-focused PE/VC funds – US$8.1 billion being raised across 51 PE/VC funds, a 40% increase over 2017 and the highest ever, according to Ernst & Young, a global consultancy. fiinews.com
